Metabolic compensation and depression in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 29, Issue 1, 2010, Pages 37-45

  Caroli, A ^a,e   Lorenzi, M ^a   Geroldi, C ^a,b   Nobili, F ^f   Paghera, B ^c   Bonetti, M ^d   Cotelli, M ^a   Frisoni, G B ^a,b  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b Psychogeriatrics Unit   (Italy)

^c IRCCS S Giovanni di Dio Fatebenefratelli ^*  (Italy)

^d Istituto Clinico Citta di Brescia   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Alzheimer's disease; Atrophy hypometabolism mismatch; Magnetic resonance imaging; Positron emission tomography; Voxel based analysis

Indexed keywords

AMYLOID BETA PROTEIN; FLUORODEOXYGLUCOSE F 18; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; CELL SURVIVAL; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; IMAGE PROCESSING; MALE; MOLECULAR MECHANICS; NERVE CELL; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; SPREADING CORTICAL DEPRESSION;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; BRAIN CHEMISTRY; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; FLUORODEOXYGLUCOSE F18; HEALTH STATUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS;

EID: 75149113224     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000257761     Document Type: Article

References (36)

1. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP: Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002; 73: 657-664.
2. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS: Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002; 17: 29-46.
3. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, Mc - Keith IG, Williams D, Ballard C, Barkhof F: A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003; 18: 895-907.
4. Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, Imabayashi E, Katoh A: Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 2002; 43: 304-311.
5. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D: Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 2005; 62: 1728-1733.
6. Chetelat G, Desgranges B, Landeau B, Mezenge F, Poline JB, de la Sayette V, Viader F, Eustache F, Baron JC: Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008; 131: 60-71.
7. Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G: Cortical abnormalities in Alzheimer's disease. Ann Neurol 1984; 16: 649-654.
8. Mosconi L: Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur J Nucl Med Mol Imaging 2005; 32: 486-510.
9. Caroli A, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, Frisoni GB: Functional compensation in incipient Alzheimer's disease. Neurobiol Aging 2008, E-pub ahead of print.
10. Dobert N, Pantel J, Frolich L, Hamscho N, Menzel C, Grunwald F: Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index. Dement Geriatr Cogn Disord 2005; 20: 63-70.
11. Lezak M, Howieson D, Loring DW: Neuropsychological Assessment, ed 4. Oxford, Oxford University Press, 2004.
12. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1997; 1: 385-401.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
14. Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, Tatsch K: European Association of Nuclear Medicine: European Association of Nuclear Medicine Procedure Guidelines for Brain Imaging using [ 18 F]FDG. Eur J Nucl Med 2002; 29: 43-48.
15. Caroli A, Testa C, Geroldi C, Nobili F, Guerra UP, Bonetti M, Frisoni GB: Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J Neurol 2007; 254: 1000-1008.
16. Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, Frisoni GB: Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J Neurol 2007; 254: 1698-1707.
17. Statistical Parametric Mapping (SPM, version 2). Available at www.fil.ion.ucl/ac.uk/ spm/software/spm2.
18. Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP: Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry 2005; 76: 112-114.
19. Ashburner J, Friston, KJ: Why voxel-based morphometry should be used. Neuroimage 2001; 14: 1238-1243.
20. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S, Flowers L, Wood F, Maldjian JA: Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007; 34: 137-143.
21. Small AS: Alzheimer disease, in living color. Nat Neurosci 2005; 8: 404-405.
22. Samuraki M, Matsunari I, Chen WP, Yajima K, Yanase D, Fujikawa A, Takeda N, Nishimura S, Matsuda H, Yamada M: Partial volume effect-corrected FDG PET and gray matter volume loss in patients with mild Alzheimer's disease. Eur J Nucl Med Mol Imaging 2007; 34: 1658-1669.
23. He Y, Wang L, Zang Y, Tian L, Zhang X, Li K, Jiang T: Regional coherence changes in the early stages of Alzheimer's disease: a combined structural and resting-state functional MRI study. Neuroimage 2007; 35: 488-500.
24. Miller SL, Celone K, DePeau K, Diamond E, Dickerson BC, Rentz D, Pihlajamaki M, Sperling RA: Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci USA 2008; 105: 2181-2186.
25. Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H: SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 1997; 38: 587-592.
26. Villain N, Desgranges B, Viader F, de la Sayette V, Mezenge F, Landeau B, Baron JC, Eustache F, Chetelat G: Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci 2008; 28: 6174-6181.
27. Schmahmann JD, Pandya DN, Wang R, Dai G, D'Arceuil HE, de Crespigny AJ, Wedeen VJ: Association fibre pathways of the brain: parallel observations from diffusion spectrum imaging and autoradiography. Brain 2007; 130: 630-653.
28. Hu NW, Smith IM, Walsh DM, Rowan MJ: Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. Brain 2008; 131: 2414-2424.
29. Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R: Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 2007; 35: 1219-1223.
30. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ: Amyloidbeta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837-842.
31. Josephs KA, Whitwell JL, Ahmed Z, Shiung MM, Weigand SD, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Dickson DW, Jack CR Jr: Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 2008; 63: 204-212.
32. Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, Vemu- ri P, Senjam ML, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW, Jack CR Jr: MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 2008; 71: 743-749.
33. Cotman CW, Anderson KJ: Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease. Adv Neurol 1988; 47: 313-335.
34. Guevara J, Dilhuydy H, Espinosa B, Delacourte A, Quirion R, Mena R, Joanette Y, Zenteno E, Robitaille Y: Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains. Histol Histopathol 2004; 19: 1075-1084.
35. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in ''probable'' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-972.
36. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P: European Task Force of Age Related White Matter Changes: a new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32: 1318-1322.